Leaderboard

En | De
Sie sind hier: Neurologie » Multiple Sklerose 20. Dezember 2025
Suchen
medline.ch
Multiple Sklerose
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Alzheimer
Epilepsie
Infektionen
Kopfschmerzen
Multiple Sklerose
Neoplasie
Neuromuskuläre Erkrankungen
Parkinson
Zerebrovaskuläre Erkrankungen
ZNS Trauma
Anderes
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 2148  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 42952  
   
Safety and efficacy of oral cladribine in relapsing multiple sclerosis: a systematic review and meta-analysis.
BMC Neurol
Alnajashi H, Almohammed HAJ, Morad AS, Bin Saddiq BW, Kushara KF, Al Zoabi BMK, Aldawsari WA, Almuhaysin FI, Gasim MA, Alharbi HA, Khan TN.
PMID: 41420217 [PubMed - indexed for MEDLINE]


Serum neurofilament light chain as a biomarker of disease control in multiple sclerosis: a real-world cross-sectional analysis of therapeutic regimens.
J Neurol
Konitsioti AM, Schweitzer F, Johannis W, Steffen F, Bittner S, Fink GR, Schroeter M, Warnke C.
PMID: 41419610 [PubMed - indexed for MEDLINE]


Remotely-delivered exercise training program among older adults with multiple sclerosis: Feasibility results of a randomized controlled trial.
Contemp Clin Trials
Zheng P, DeJonge SR, DuBose NG, Kidwell-Chandler A, Martin TB, Huynh TLT, Phillips SA, Duffecy J, Motl RW.
PMID: 41419055 [PubMed - as supplied by publisher]


Discriminative ability of the six-minute walk distance in identifying fallers in multiple sclerosis.
Mult Scler Relat Disord
Bozdemir C, Turan K, Tekgol Uzuner G.
PMID: 41418489 [PubMed - as supplied by publisher]


Feasibility and efficacy of peak-velocity interval training vs. moderate-intensity walking training in people with multiple sclerosis with severe fatigue and walking impairment: A pilot randomized controlled trial.
Mult Scler Relat Disord
Cleland BT, Jeng B, Brown N, Motl RW, Madhavan S.
PMID: 41418486 [PubMed - as supplied by publisher]


Exploring shared diagnostic genes and molecular mechanisms in multiple sclerosis and psoriasis through bioinformatics analysis and machine learning.
Biochem Biophys Res Commun
Kong Y, Li X, Yang F, Wang J, Guo P, Ren C, Duan Z, Bi M, Wang Y, Liu F, Zhang Y.
PMID: 41418349 [PubMed - as supplied by publisher]


Thalamic and cerebral white matter volumes allow for identification of cognitively impaired patients with early relapsing-remitting multiple sclerosis.
Neurol Neurochir Pol
Wnuk M, Lasek J, Gliniak M, Schneider Z, Marona M, Kaczówka K, Bryll A, Popiela T, Krzy, S, Drabik L.
PMID: 41416488 [PubMed - as supplied by publisher]


Current trends in the teatment of multiple sclerosis.
Ceska Slov Farm
Libertínová J.
PMID: 41412781 [PubMed - indexed for MEDLINE]


Association of Brain Age With Physical Disability and Cognitive Impairment in People With Multiple Sclerosis of the Same Age.
Neurology
Bos L, Wink AM, Cole JH, Strijbis EMM, Moraal B, Killestein J, Vrenken H, Uitdehaag BMJ, Barkhof F, Schoonheim MM, Jasperse B.
PMID: 41411602 [PubMed - indexed for MEDLINE]


Revised diagnostic criteria for multiple sclerosis.
Tidsskr Nor Laegeforen
Høgestøl EA, Sowa P, Holmøy T, Bø L, Nygaard GO, Wergeland S.
PMID: 41410973 [PubMed - in process]


Motor imagery training promotes motor learning and brain plasticity without fatigability in people with progressive multiple sclerosis.
Eur J Phys Rehabil Med
Biggio M, Pedullà L, Albergoni A, Bellosta A, Tacchino A, Podda J, Bonzano L, Avanzino L, Brichetto G, Bove M, Bisio A.
PMID: 41410550 [PubMed - as supplied by publisher]


Ocrelizumab versus Natalizumab in Relapsing-Remitting Multiple Sclerosis: A Registry-Linked Electronic Health Records Study.
medRxiv
Huang F, Zhu W, Hou J, Morini Sweet S, Han Y, Wen J, Liao KP, Cai T, Chitnis T, Bourgeois FT, Xia Z, Cai T.
PMID: 41409680 [PubMed]


Efficacy of caffeine supplementation on fatigue in patients with multiple sclerosis: A randomized double-blind placebo-controlled trial.
Mult Scler Relat Disord
Baghbanian SM, Gharanjik A, Ghazaeian M, Bakhshi A, Hosseinnataj A.
PMID: 41406935 [PubMed - as supplied by publisher]


Siponimod enhances brain-derived neurotrophic factor secretion from immune cells in multiple sclerosis: A longitudinal study.
J Neurol Sci
Fuchs L, Avizov R, Karni A, Golan M.
PMID: 41406549 [PubMed - as supplied by publisher]


The Value of Oligoclonal Bands in Multiple Sclerosis Compared to Other Neurological Disorders: A Retrospective Data Analysis From an Austrian Tertiary Center.
Eur J Neurol
Monschein T, Scheicher B, Ponleitner M, Krajnc N, Föttinger F, Zrzavy T, Rommer P, Kornek B, Bsteh G, Perkmann T, Berger T, Leutmezer F.
PMID: 41405159 [PubMed - indexed for MEDLINE]


Reduced CD40 expression in B cell subsets of individuals with radiologically isolated syndrome.
Front Immunol
Keller CW, Stein K, Vilaseca A, Villar LM, Álvarez-Bravo G, Protopapa M, Shin J, Fissolo N, Martínez-Rodríguez JE, Quiroga-Varela A, García-Sarreón A, Gutiérrez L, Midaglia L, Montalban X, Lünemann JD, Comabella M.
PMID: 41403945 [PubMed - indexed for MEDLINE]


Antibiotic Administration and Risk of Multiple Sclerosis: a Systematic Review and Meta-Analysis.
Maedica (Bucur)
Naser Moghadasi A, Rastkar M, Feili M, Ghajarzadeh M, Mohammadi A, Ghajarzadeh M.
PMID: 41403803 [PubMed]


Did COVID-19 Pandemic Change the Course of Multiple Sclerosis? A Retrospective Eight-Year Study.
Health Sci Rep
Puz P, Konieczna M, Maciejowska K, Tarnawska Z, Nowakowska Z, Glodny M, Lasek-Bal A.
PMID: 41403580 [PubMed]


RAUM-GANs: a multi-layer GAN-enhanced framework for accurate multiple sclerosis lesion segmentation in MRI.
Sci Rep
Alsayat A, Mostafa AM, Elmezain M, Alamri M, Alruwaili M, Alkhomsan MN, Alshammeri M, Ezz M, Alharbi S, Mostafa E, Said W.
PMID: 41402470 [PubMed - indexed for MEDLINE]


Impact of HIV on disability progression in multiple sclerosis: An observational retrospective matched cohort study.
Rev Neurol (Paris)
Moulignier A, Guillaume J, Pourcher V, Maillart E, Januel E, Papeix C.
PMID: 41402227 [PubMed - as supplied by publisher]


   
   Artikel 1 - 20 / 42952    Seite 1 von 2148  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1